Quito's cancer registry counted 93,821 new cancers from 1985 to 2017; incidence rose by about 2% a year in both sexes and mortality by 2.0% a year in men and 1.3% in women, with breast, prostate, colorectal, thyroid cancer and lymphoma increasing and the fall in cervical and stomach cancer stalling.
Published as "Cancer incidence and mortality in Quito: information to monitor cancer control policies". The authors, from the Registro Nacional de Tumores at SOLCA Quito, analysed age-standardised incidence and mortality in the city of Quito from 1985 to 2017 with joinpoint regression, and discussed the results against Ecuador's 2017 national cancer strategy. Mortality figures come from the national statistics institute and are checked against the registry's own case records.
The latest published rates from the Quito registry, which predates Ecuador's other population-based registries. They show thyroid cancer overtaking breast cancer in Quito's women and cervical and stomach cancer no longer falling, which the authors read as a reason to strengthen prevention.
Shares SOLCA Núcleo de Quito, Hospital Oncológico Solón Espinosa Ayala, Registro Nacional de Tumores (Quito population-based cancer registry), Thyroid cancer, Gastric & gastro-oesophageal junction cancer.
Shares SOLCA Núcleo de Quito, Hospital Oncológico Solón Espinosa Ayala, Ministerio de Salud Pública del Ecuador, Cervical cancer.
Shares SOLCA Núcleo de Quito, Hospital Oncológico Solón Espinosa Ayala, Ministerio de Salud Pública del Ecuador, Breast cancer (all types).
Shares Ministerio de Salud Pública del Ecuador, Gastric & gastro-oesophageal junction cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/